UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192]

European journal of cancer (1990), 2023-05, Vol.184, p.197-198

2023

Volltextzugriff (PDF)

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2528-2533

2011

Volltextzugriff (PDF)

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.e338-e346

2019

Volltextzugriff (PDF)

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

The lancet oncology, 2019-07, Vol.20 (7), p.1023-1034

2019

Volltextzugriff (PDF)

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8636-8645

2005

Volltextzugriff (PDF)

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Annals of oncology, 2017-12, Vol.28 (12), p.2994-2999

2017

Volltextzugriff (PDF)

Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data

Cancers, 2024-01, Vol.16 (2), p.267

2024

Volltextzugriff (PDF)

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS –GROUP). Part II

Cancer treatment reviews, 2021-09, Vol.99, p.102260-102260, Article 102260

2021

Volltextzugriff (PDF)

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS – GROUP). Part I

Cancer treatment reviews, 2021-09, Vol.99, p.102259, Article 102259

2021

Volltextzugriff (PDF)

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

Cancer, 2005-10, Vol.104 (8), p.1706-1712

2005

Volltextzugriff (PDF)

Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study

Targeted oncology, 2018-02, Vol.13 (1), p.81-87

2018

Volltextzugriff (PDF)

Are Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma?

Journal of oral and maxillofacial surgery, 2019-09, Vol.77 (9), p.1906-1914

2019

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry

ESMO open, 2023-12, Vol.8 (6), p.102045-102045, Article 102045

2023

Volltextzugriff (PDF)

MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study

Molecular cancer therapeutics, 2014-01, Vol.13 (1), p.249-259

2014

Volltextzugriff (PDF)

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: A Phase II trial by the Spanish Group for Research on Sarcomas (GEIS)

Cancer, 2004-04, Vol.100 (7), p.1498-1506

2004

Volltextzugriff (PDF)

Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11004-11004

2017

Volltextzugriff (PDF)

Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10594-10594

2014

Volltextzugriff (PDF)

Tongue Spindle Cell Rhabdomyosarcoma: A Rare Case Report and Literature Review

Journal of maxillofacial and oral surgery, 2021-09, Vol.20 (3), p.464-469

2021

Volltextzugriff (PDF)

Role of FDG-PET-CT (PET) in predicting outcome of advanced hepatocellular carcinoma (aHCC) patients (pts) treated with sorafenib (SB): A prospective controlled study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4104-4104

2014

Volltextzugriff (PDF)

Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias-A study of the Spanish Group for Research on Sarcomas (GEIS)

Journal of surgical oncology, 2004-10, Vol.88 (1), p.44-49

2004

Volltextzugriff (PDF)

Brain metastases from colorectal carcinoma

Tumori, 2001-09, Vol.87 (5), p.332-334

2001

Volltextzugriff (PDF)

Serum markers and prognosis in locally advanced breast cancer

Tumori, 2005-11, Vol.91 (6), p.522-530

2005

Volltextzugriff (PDF)

Sequential dose‐dense doxorubicin and ifosfamide for advanced soft tissue sarcomas

Cancer, 2004-04, Vol.100 (7), p.1498-1506

2004

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(29)
Berichte
(1)

Sprache

Englisch
(30)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Oncology
(22)
Humans
(16)
Middle Aged
(14)
Female
(13)
Adult
(12)
Male
(12)
Aged
(11)
Tumors
(9)
Sarcoma
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Sarcoma - Drug Therapy
(6)
Biological And Medical Sciences
(5)
Chemotherapy
(5)
Medical Sciences
(5)
Prognosis
(5)
Soft Tissue Sarcoma
(5)
Survival Analysis
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(5)
Cancer
(4)
Anti-Cancer Drugs
(2)
Cancer Treatment Reviews
(2)
Cancers
(2)
European Journal Of Cancer
(2)
Tumori
(2)
Annals Of Oncology
(1)
Esmo Open
(1)
Journal Of Maxillofacial And Oral Surgery
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study

Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192]

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS –GROUP). Part II

Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS – GROUP). Part I

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma : A study by the Spanish group for research on sarcomas

Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study

Are Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma?

Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry

MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study

Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: A Phase II trial by the Spanish Group for Research on Sarcomas (GEIS)

Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118)

Phase II study of gemcitabine (GEM) plus sirolimus (SIR) in previously treated patients with advanced soft tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Tongue Spindle Cell Rhabdomyosarcoma: A Rare Case Report and Literature Review

Role of FDG-PET-CT (PET) in predicting outcome of advanced hepatocellular carcinoma (aHCC) patients (pts) treated with sorafenib (SB): A prospective controlled study

Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias-A study of the Spanish Group for Research on Sarcomas (GEIS)

Brain metastases from colorectal carcinoma

Serum markers and prognosis in locally advanced breast cancer

Sequential dose‐dense doxorubicin and ifosfamide for advanced soft tissue sarcomas

Suchergebnisse filtern